Basic Information
| LncRNA/CircRNA Name | TDRG1 |
| Synonyms | NA |
| Region | GRCh38_6:40334954-40379887 |
| Ensemble | ENSG00000204091 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | cervical cancer |
| ICD-0-3 | C53 |
| Methods | qPCR, Luciferase reporter assay, Western blot, RIP |
| Sample | cervical cancer tissues,cell line |
| Expression Pattern | up-regulated |
| Function Description | LncRNA TDRG1 expression was notably increased in cervical cancer tissues and cancer cells. |
| Pubmed ID | 31539116 |
| Year | 2019 |
| Title | LncRNA TDRG1 functions as an oncogene in cervical cancer through sponging miR-330-5p to modulate ELK1 expression. |
External Links
| Links for TDRG1 | GenBank HGNC NONCODE |
| Links for cervical cancer | OMIM COSMIC |